Press Releases Qlucore AB

Equities

QCORE

SE0016829824

Delayed Nasdaq Stockholm Other stock markets 09:42:12 16/05/2024 BST			5-day change	1st Jan Change
7.9 ^SEK	-1.86%		-2.47%	+3.27%

04-08	Qlucore Announces the Launch of the Qlucore Omics Explorer Cloud Version	CI
02-28	Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Rigshospitalet in Denmark implements Qlucore Insights in analysis workflow for leukemia patients	04-30	AQ
Qlucore Omics Explorer expands to the cloud - even more flexible data analysis	04-08	AQ
Interim report 1 May 2023 - 31 January 2024	02-28	AQ
Grant from EU	02-27	AQ
Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 November 2023 – 31 January 2024	02-27	AQ
Qlucore Diagnostics for Pediatric leukemia takes a Significant step closer to CE marking	01-30	AQ
Sahlgrenska Hospital invests in precision diagnostics with Qlucore Insights	01-16	AQ
Boehringer Ingelheim signs a two-year agreement with Qlucore	01-11	AQ
Swedish innovation evaluated for clinical diagnosis of pediatric leukemia	12-13	AQ
Equity Research \| QLUCORE: Long term potential clouded by likely capital raise	11-30	AQ
Interim report, 1 May - 31 October	11-28	AQ
Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 August – 31 October 2023	11-28	AQ
Bulletin from the annual general meeting of Qlucore AB (publ)	07/09/23	AQ
QLUCORE: Streamlining focus to extend financial runway	05/09/23	AQ
Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 May – 31 July 2023	29/08/23	AQ
Qlucore recognized by strategic innovation program for MedTech	21/08/23	AQ
Equity Research \| QLUCORE: Delayed CE approval suggests upcoming need for additional financing	01/06/23	AQ
Qlucore presents promising results in the field of lung cancer diagnosis	30/05/23	AQ
Invitation to presentation including Q&A session of Qlucore’s year end report for 2022/2023	29/05/23	AQ
Qlucore's software for cancer diagnostics on its way to obtaining CE certification	22/05/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Qlucore AB

Equities

QCORE

SE0016829824

Press Releases

Filters